3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
18
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
208
Neoplasms
130
Polycystic Ovary Syndrome
107
Carcinoma, Hepatocellular
82
Colorectal Neoplasms
77
Prostatic Neoplasms
70
Stomach Neoplasms
55
Lung Neoplasms
51
Precursor Cell Lymphoblastic Leukemia-Lymphoma
49
Carcinoma, Non-Small-Cell Lung
43
Pain, Postoperative
42
Pancreatic Neoplasms
41
Head and Neck Neoplasms
38
Pain
37
Liver Neoplasms
36
Leukemia, Myeloid, Acute
32
Leiomyoma
32
Keratosis, Actinic
31
Colonic Neoplasms
31
Recurrence
30
Neoplasm Metastasis
29
Multiple Myeloma
28
Infertility
28
Brain Neoplasms
28
Uterine Cervical Neoplasms
26
Urinary Bladder Neoplasms
24
Ovarian Neoplasms
24
Lymphoma
24
Esophageal Neoplasms
23
Obesity
22
Interventions
palbociclib
1
exemestane
1
Vinorelbine
1
Tamoxifen
1
Paclitaxel
1
Letrozole
1
Fulvestrant
1
Epirubicin
1
Drug Therapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER
×
Patient Acceptance of Health Care
×
Clear all
NCT03355157
2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4
Completed
130 enrolled